<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425709</url>
  </required_header>
  <id_info>
    <org_study_id>Hyst 4</org_study_id>
    <nct_id>NCT02425709</nct_id>
  </id_info>
  <brief_title>Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy in Post Menopausal Women</brief_title>
  <official_title>Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy in Post Menopausal Women: A Randomized Double Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of Tramadol and diclofenac in&#xD;
      reducing pain during outpatient hysteroscopy in postmenopausal women. Postmenopausal women&#xD;
      undergoing outpatient hysteroscopy in Cairo university will be divided into 3 groups, the&#xD;
      first group will receive Tramadol 50 mg 1 hour before the procedure, the second group will&#xD;
      receive diclofenac 50mg 1 hour before the procedure and the third will receive a placebo.&#xD;
      Pain will be assessed by a visual analogue scale.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hysteroscopic examination is currently the most informative investigation for patients with&#xD;
      abnormal uterine bleeding. Outpatient hysteroscopy involves the use of miniaturized&#xD;
      endoscopic equipment to directly visualise the endometrial cavity, without the need of formal&#xD;
      theatre facilities, general or regional anaesthesia.&#xD;
&#xD;
      Outpatient hysteroscopy is increasingly being used as a cost-effective alternative to&#xD;
      in-patient hysteroscopy under general anaesthesia. Like other outpatient gynaecological&#xD;
      procedures, however, it has the potential to cause pain severe enough for the procedure to be&#xD;
      abandoned.&#xD;
&#xD;
      Opioid analgesics are widely used for the control of moderate to severe pain. Tramadol&#xD;
      hydrochloride, a synthetic opioid is an orally active, clinically effective centrally acting&#xD;
      analgesic having a lower incidence of respiratory depression, cardiac depression, side&#xD;
      effects on smooth muscle and abuse potential as compared to typical opioid agents.&#xD;
&#xD;
      Diclofenac is a non steroidal anti inflammatory drug which inhibits the cyclooxygenase&#xD;
      enzyme.&#xD;
&#xD;
      The study will be conducted in the outpatient hysteroscopy clinic in Cairo university&#xD;
      hospitals. All postmenopausal patients attending the outpatient hysteroscopy clinic will be&#xD;
      invited to participate in the study. The invitation will include a clear full explanation of&#xD;
      the study and patients will provide written consents.&#xD;
&#xD;
      Tramadol, diclofenac and placebo will be enclosed in sealed envelopes which will be numbered&#xD;
      using computer generated random table. Neither the patient nor the physician will be aware of&#xD;
      the drug used. 210 women will be categorized into 3 groups: Group I will receive Tramadol&#xD;
      50mg (Tramal ®, Memphis,) orally 1 hour before the procedure, group II will receive&#xD;
      diclofenac 50mg (voltaren®, Novartis) 1 hour before the procedure, and group III will receive&#xD;
      placebo acting as the control group.&#xD;
&#xD;
      Full history will be taken followed by general and local examination. The procedure will be&#xD;
      done in the lithotomy position. Hysteroscopy will be done using a 5mm outer diameter&#xD;
      continuous flow hysteroscope with a French working channel and a 30 degrees direction of view&#xD;
      provided by Techno GmbH and CO. The hysteroscope will be introduced using the vaginoscopy&#xD;
      technique, in which no speculum will be used. The cervix will be detected and the external os&#xD;
      will be identified using the hysteroscope. The hysteroscope will be introduced in the uterine&#xD;
      cavity. Saline will be used as the distension medium and the pressure will be set at 100mm&#xD;
      Hg.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain during the procedure measured using a visual analogue scale</measure>
    <time_frame>5 minutes after starting the procedure</time_frame>
    <description>Women will be asked to score their pain using a visual analogue scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain immediately after the procedure measured using a visual analogue scale</measure>
    <time_frame>1 minute after completing the procedure</time_frame>
    <description>Women will be asked to score their pain using a visual analogue scale</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Hysteroscopy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>women will receive oral diclofenac 50 mg 1 hour before the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women will receive oral tramadol 50 mg 1 hour before the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women will receive a placebo 1 hour before the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>Women will receive oral diclofenac 50 mg 1 hour before the procedure</description>
    <arm_group_label>Diclofenac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>Women will receive oral tramadol 50 mg 1 hour before the procedure</description>
    <arm_group_label>Tramadol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Women will receive an oral placebo 1 hour before the procedure</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post menopausal women.&#xD;
&#xD;
          -  Indication for outpatient hysteroscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to tramadol or diclofenac&#xD;
&#xD;
          -  Cardiac renal or gastric disease.&#xD;
&#xD;
          -  Diabetes or hypertension&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>AbdelGany M Hassan, MRCOG, MD</last_name>
    <phone>+201017801604</phone>
    <email>abdelgany2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo university hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AbdelGany Hassan, MRCOG, MD</last_name>
      <phone>002 01017801604</phone>
      <email>abdelgany2@gmail.com</email>
    </contact>
    <investigator>
      <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohamed MM Kotb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Ahmad G, Attarbashi S, O'Flynn H, Watson AJ. Pain relief in office gynaecology: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2011 Mar;155(1):3-13. doi: 10.1016/j.ejogrb.2010.11.018. Epub 2011 Jan 20. Review.</citation>
    <PMID>21255900</PMID>
  </reference>
  <reference>
    <citation>van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007 Jun;114(6):664-75. Review.</citation>
    <PMID>17516956</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>April 21, 2015</study_first_submitted>
  <study_first_submitted_qc>April 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2015</study_first_posted>
  <last_update_submitted>January 20, 2017</last_update_submitted>
  <last_update_submitted_qc>January 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>AbdelGany Hassan</investigator_full_name>
    <investigator_title>Lecturer of Gynecology and Obstetrics</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

